May 30, 2017
Inventiva welcomes new Board memeber
Inventiva, a biopharmaceutical company developing innovative therapies, particularly to treat fibrosis, has appointed Dr Nanna Lüneborg as its Board member, succeeding Mr Philippe Goupit.
Pharmaceuticals, Biotechnology and Life Sciences
Inventiva, a biopharmaceutical company developing innovative therapies, particularly to treat fibrosis, has appointed Dr Nanna Lüneborg as its Board member, succeeding Mr Philippe Goupit.
Inventiva, a biopharmaceutical company developing innovative therapies, particularly to treat fibrosis, has reported its financial results for the year ended December 31, 2016.